
Utah-based Sera Prognostics to Raise $50 Million to Help Leverage Proteomics to Boost its Efforts to Identify Preterm Birth Candidates and Improve Maternal and Neonatal Health
In plans announced earlier this week, Salt Lake City, Utah-based Sera Prognostics (NASDAQ:SERA) priced a secondary public offering on Monday, 10 February 2025, with plans to raise $50 million in gross proceeds yesterday, 12 February 2025.
As of 07:05am MT today (Thursday, 13 February 2025), Sera has not